Cordlife Group Limited (CLIFF)
OTCMKTS · Delayed Price · Currency is USD
0.1721
0.00 (0.00%)
Aug 24, 2025, 8:00 PM EDT
Cordlife Group Revenue
Cordlife Group had revenue of 19.19M SGD in the half year ending June 30, 2025, a decrease of -32.24%. This brings the company's revenue in the last twelve months to 37.64M, up 2.83% year-over-year. In the year 2024, Cordlife Group had annual revenue of 27.65M, down -50.39%.
Revenue (ttm)
37.64M SGD
Revenue Growth
+2.83%
P/S Ratio
1.45
Revenue / Employee
69.97K SGD
Employees
538
Market Cap
42.95M USD
Revenue Chart
* This company reports financials in SGD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 27.65M | -28.08M | -50.39% |
Dec 31, 2023 | 55.73M | 574.00K | 1.04% |
Dec 31, 2022 | 55.16M | -1.51M | -2.67% |
Dec 31, 2021 | 56.67M | -2.32M | -3.93% |
Dec 31, 2020 | 58.99M | -2.59M | -4.21% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |